Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
‘Next wave of IPOs’ will arrive in summer, predicts VC partner
Medicxi co-founder Francesco De Rubertis pointed to the current popularity of secondary stock offerings as a sign that “investors are excited.”
James Waldron
May 3, 2024 10:49am
Fierce Biotech Fundraising Tracker: Reunion, Xaira & more
May 2, 2024 8:00am
BridgeBio taps VCs for $200M to fund cancer-focused spinout
May 2, 2024 7:00am
Reunion nets $103M, one of the largest for a psychedelic biotech
May 2, 2024 6:30am
Bob Nelsen on megarounds, Altos and psychedelics
May 1, 2024 10:56am
Fibrosis-focused Endeavor bags $132.5M series C
Apr 24, 2024 7:30am